nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—ABCB1—adrenal gland cancer	0.837	1	CbGaD
Clomipramine—SLC6A2—sympathetic nervous system—adrenal gland cancer	0.0149	0.135	CbGeAlD
Clomipramine—GSTP1—urine—adrenal gland cancer	0.0111	0.101	CbGeAlD
Clomipramine—HTR2A—sympathetic nervous system—adrenal gland cancer	0.00894	0.0813	CbGeAlD
Clomipramine—HTR2A—vein—adrenal gland cancer	0.00837	0.0761	CbGeAlD
Clomipramine—CYP2C19—urine—adrenal gland cancer	0.00767	0.0698	CbGeAlD
Clomipramine—CYP1A2—urine—adrenal gland cancer	0.00627	0.057	CbGeAlD
Clomipramine—HTR2A—urine—adrenal gland cancer	0.0049	0.0446	CbGeAlD
Clomipramine—CYP3A4—urine—adrenal gland cancer	0.00454	0.0413	CbGeAlD
Clomipramine—CYP2D6—urine—adrenal gland cancer	0.00446	0.0406	CbGeAlD
Clomipramine—HRH2—cardiac atrium—adrenal gland cancer	0.00339	0.0308	CbGeAlD
Clomipramine—HRH2—adrenal gland—adrenal gland cancer	0.00296	0.0269	CbGeAlD
Clomipramine—GSTP1—adrenal cortex—adrenal gland cancer	0.00295	0.0268	CbGeAlD
Clomipramine—GSTP1—gonad—adrenal gland cancer	0.00244	0.0222	CbGeAlD
Clomipramine—GSTP1—cardiac atrium—adrenal gland cancer	0.00244	0.0222	CbGeAlD
Clomipramine—HTR2B—adrenal cortex—adrenal gland cancer	0.00243	0.0221	CbGeAlD
Clomipramine—GSTP1—pituitary gland—adrenal gland cancer	0.00238	0.0217	CbGeAlD
Clomipramine—GSTP1—adrenal gland—adrenal gland cancer	0.00213	0.0194	CbGeAlD
Clomipramine—ALB—adrenal gland—adrenal gland cancer	0.00182	0.0166	CbGeAlD
Clomipramine—SLC6A2—gonad—adrenal gland cancer	0.00179	0.0163	CbGeAlD
Clomipramine—HTR2B—adrenal gland—adrenal gland cancer	0.00175	0.016	CbGeAlD
Clomipramine—SLC6A2—adrenal gland—adrenal gland cancer	0.00156	0.0142	CbGeAlD
Clomipramine—ADRA2A—gonad—adrenal gland cancer	0.00126	0.0115	CbGeAlD
Clomipramine—ADRA2A—cardiac atrium—adrenal gland cancer	0.00126	0.0115	CbGeAlD
Clomipramine—ADRA2A—pituitary gland—adrenal gland cancer	0.00123	0.0112	CbGeAlD
Clomipramine—ADRA2A—adrenal gland—adrenal gland cancer	0.0011	0.01	CbGeAlD
Clomipramine—HTR2A—gonad—adrenal gland cancer	0.00107	0.00978	CbGeAlD
Clomipramine—HTR2A—pituitary gland—adrenal gland cancer	0.00105	0.00954	CbGeAlD
Clomipramine—HTR2A—adrenal gland—adrenal gland cancer	0.000937	0.00852	CbGeAlD
Clomipramine—ABCB1—adrenal cortex—adrenal gland cancer	0.000851	0.00774	CbGeAlD
Clomipramine—ABCB1—gonad—adrenal gland cancer	0.000704	0.00641	CbGeAlD
Clomipramine—ABCB1—pituitary gland—adrenal gland cancer	0.000687	0.00625	CbGeAlD
Clomipramine—ABCB1—adrenal gland—adrenal gland cancer	0.000614	0.00558	CbGeAlD
Clomipramine—Triflupromazine—ABCB1—adrenal gland cancer	0.000476	0.121	CrCbGaD
Clomipramine—Clobazam—ABCB1—adrenal gland cancer	0.000424	0.108	CrCbGaD
Clomipramine—Chlorprothixene—ABCB1—adrenal gland cancer	0.000334	0.0847	CrCbGaD
Clomipramine—Flurazepam—ABCB1—adrenal gland cancer	0.000312	0.0791	CrCbGaD
Clomipramine—Trimipramine—ABCB1—adrenal gland cancer	0.000308	0.0782	CrCbGaD
Clomipramine—Promethazine—ABCB1—adrenal gland cancer	0.000297	0.0753	CrCbGaD
Clomipramine—Doxepin—ABCB1—adrenal gland cancer	0.000294	0.0746	CrCbGaD
Clomipramine—Trifluoperazine—ABCB1—adrenal gland cancer	0.000293	0.0743	CrCbGaD
Clomipramine—Desipramine—ABCB1—adrenal gland cancer	0.00027	0.0684	CrCbGaD
Clomipramine—Diazepam—ABCB1—adrenal gland cancer	0.000247	0.0628	CrCbGaD
Clomipramine—Chlorpromazine—ABCB1—adrenal gland cancer	0.00023	0.0583	CrCbGaD
Clomipramine—Imipramine—ABCB1—adrenal gland cancer	0.000229	0.058	CrCbGaD
Clomipramine—Amitriptyline—ABCB1—adrenal gland cancer	0.000227	0.0577	CrCbGaD
Clomipramine—HTR2B—GPCR ligand binding—POMC—adrenal gland cancer	6.69e-05	0.00137	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—SPARC—adrenal gland cancer	6.54e-05	0.00134	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—CDC42—adrenal gland cancer	6.44e-05	0.00132	CbGpPWpGaD
Clomipramine—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	6.41e-05	0.00131	CbGpPWpGaD
Clomipramine—ALB—Metabolism—SDHB—adrenal gland cancer	6.38e-05	0.00131	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—GNRH1—adrenal gland cancer	6.37e-05	0.0013	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—GNAS—adrenal gland cancer	6.34e-05	0.0013	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	6.32e-05	0.00129	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—PRKACA—adrenal gland cancer	6.29e-05	0.00129	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—GNRH1—adrenal gland cancer	6.27e-05	0.00128	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	6.24e-05	0.00128	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GNRHR—adrenal gland cancer	6.18e-05	0.00127	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	6.18e-05	0.00127	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	6.16e-05	0.00126	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	6.16e-05	0.00126	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—GNAS—adrenal gland cancer	6.15e-05	0.00126	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—TSHR—adrenal gland cancer	6.14e-05	0.00126	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ZNRF3—adrenal gland cancer	5.94e-05	0.00122	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—CDC42—adrenal gland cancer	5.93e-05	0.00121	CbGpPWpGaD
Clomipramine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	5.89e-05	0.00121	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—CDC42—adrenal gland cancer	5.88e-05	0.0012	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—CDC42—adrenal gland cancer	5.85e-05	0.0012	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SPRY2—adrenal gland cancer	5.82e-05	0.00119	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—GNRH1—adrenal gland cancer	5.81e-05	0.00119	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	5.75e-05	0.00118	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—SDHB—adrenal gland cancer	5.73e-05	0.00117	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—IGF2—adrenal gland cancer	5.72e-05	0.00117	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TSHR—adrenal gland cancer	5.68e-05	0.00116	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—GNAS—adrenal gland cancer	5.67e-05	0.00116	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—GNAS—adrenal gland cancer	5.62e-05	0.00115	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	5.6e-05	0.00115	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—SDHB—adrenal gland cancer	5.59e-05	0.00115	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—TSHR—adrenal gland cancer	5.59e-05	0.00114	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—GNAS—adrenal gland cancer	5.59e-05	0.00114	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—PRKACA—adrenal gland cancer	5.52e-05	0.00113	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	5.41e-05	0.00111	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	5.41e-05	0.00111	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—POMC—adrenal gland cancer	5.4e-05	0.00111	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—POMC—adrenal gland cancer	5.4e-05	0.00111	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—CDC42—adrenal gland cancer	5.34e-05	0.00109	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MEN1—adrenal gland cancer	5.34e-05	0.00109	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SPRY2—adrenal gland cancer	5.32e-05	0.00109	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PRKACA—adrenal gland cancer	5.31e-05	0.00109	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	5.27e-05	0.00108	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—RRM1—adrenal gland cancer	5.21e-05	0.00107	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—SDHD—adrenal gland cancer	5.21e-05	0.00107	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TSHR—adrenal gland cancer	5.18e-05	0.00106	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—GNAS—adrenal gland cancer	5.1e-05	0.00104	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—PRKACA—adrenal gland cancer	5.08e-05	0.00104	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.02e-05	0.00103	CbGpPWpGaD
Clomipramine—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	4.99e-05	0.00102	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—POMC—adrenal gland cancer	4.91e-05	0.001	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MEN1—adrenal gland cancer	4.87e-05	0.000998	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.82e-05	0.000986	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	4.78e-05	0.000978	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—CDC42—adrenal gland cancer	4.74e-05	0.000972	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	4.7e-05	0.000963	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—GNRH1—adrenal gland cancer	4.69e-05	0.00096	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—POMC—adrenal gland cancer	4.69e-05	0.00096	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—CDC42—adrenal gland cancer	4.68e-05	0.000958	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—POMC—adrenal gland cancer	4.64e-05	0.000951	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	4.59e-05	0.00094	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—GNAS—adrenal gland cancer	4.53e-05	0.000928	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—IGF2—adrenal gland cancer	4.51e-05	0.000924	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.51e-05	0.000923	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CDC42—adrenal gland cancer	4.51e-05	0.000923	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—GNAS—adrenal gland cancer	4.47e-05	0.000916	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SDHB—adrenal gland cancer	4.46e-05	0.000914	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	4.41e-05	0.000903	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IGF2—adrenal gland cancer	4.34e-05	0.000889	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—CDC42—adrenal gland cancer	4.31e-05	0.000882	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—GNAS—adrenal gland cancer	4.3e-05	0.000882	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SPRY2—adrenal gland cancer	4.29e-05	0.000878	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—POMC—adrenal gland cancer	4.27e-05	0.000874	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IGF1R—adrenal gland cancer	4.2e-05	0.00086	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	4.18e-05	0.000857	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TSHR—adrenal gland cancer	4.18e-05	0.000856	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—POMC—adrenal gland cancer	4.14e-05	0.000849	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	4.12e-05	0.000844	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—GNAS—adrenal gland cancer	4.12e-05	0.000843	CbGpPWpGaD
Clomipramine—ALB—Metabolism—RRM1—adrenal gland cancer	4.11e-05	0.000842	CbGpPWpGaD
Clomipramine—ALB—Metabolism—SDHD—adrenal gland cancer	4.11e-05	0.000842	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	4.1e-05	0.000841	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PRKACA—adrenal gland cancer	4.07e-05	0.000834	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	4.07e-05	0.000834	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	4.01e-05	0.000822	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	3.94e-05	0.000806	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MEN1—adrenal gland cancer	3.93e-05	0.000805	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—MED12—adrenal gland cancer	3.89e-05	0.000796	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.87e-05	0.000793	CbGpPWpGaD
Clomipramine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	3.85e-05	0.000789	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	3.8e-05	0.000778	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—POMC—adrenal gland cancer	3.78e-05	0.000775	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—POMC—adrenal gland cancer	3.76e-05	0.000771	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	3.75e-05	0.000768	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	3.74e-05	0.000766	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	3.72e-05	0.000763	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PRKACA—adrenal gland cancer	3.72e-05	0.000762	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GNRH1—adrenal gland cancer	3.7e-05	0.000759	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—PTGS2—adrenal gland cancer	3.7e-05	0.000759	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—RRM1—adrenal gland cancer	3.69e-05	0.000756	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—SDHD—adrenal gland cancer	3.69e-05	0.000756	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	3.63e-05	0.000743	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TERT—adrenal gland cancer	3.61e-05	0.00074	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—SDHD—adrenal gland cancer	3.6e-05	0.000738	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—RRM1—adrenal gland cancer	3.6e-05	0.000738	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	3.58e-05	0.000733	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	3.57e-05	0.000732	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.51e-05	0.00072	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CDC42—adrenal gland cancer	3.46e-05	0.000708	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	3.45e-05	0.000706	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—POMC—adrenal gland cancer	3.43e-05	0.000704	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	3.41e-05	0.000699	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	3.4e-05	0.000697	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	3.4e-05	0.000695	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	3.4e-05	0.000695	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.39e-05	0.000695	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	3.39e-05	0.000694	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IGF2—adrenal gland cancer	3.33e-05	0.000682	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	3.3e-05	0.000676	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—GNAS—adrenal gland cancer	3.3e-05	0.000676	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.25e-05	0.000666	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	3.25e-05	0.000666	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IGF1R—adrenal gland cancer	3.22e-05	0.00066	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CDC42—adrenal gland cancer	3.15e-05	0.000646	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—BAD—adrenal gland cancer	3.14e-05	0.000644	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	3.1e-05	0.000636	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MED12—adrenal gland cancer	3.07e-05	0.000628	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	3.05e-05	0.000625	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IGF2—adrenal gland cancer	3.04e-05	0.000623	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—GNAS—adrenal gland cancer	3.01e-05	0.000617	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	3e-05	0.000614	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IGF1R—adrenal gland cancer	2.94e-05	0.000602	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—POMC—adrenal gland cancer	2.9e-05	0.000594	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SDHD—adrenal gland cancer	2.88e-05	0.000589	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—RRM1—adrenal gland cancer	2.88e-05	0.000589	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—BRAF—adrenal gland cancer	2.86e-05	0.000586	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	2.83e-05	0.000581	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—EGFR—adrenal gland cancer	2.77e-05	0.000568	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TERT—adrenal gland cancer	2.77e-05	0.000568	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	2.77e-05	0.000568	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MED12—adrenal gland cancer	2.75e-05	0.000564	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.74e-05	0.000561	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.73e-05	0.000559	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MED12—adrenal gland cancer	2.69e-05	0.00055	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	2.65e-05	0.000543	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	2.6e-05	0.000534	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	2.54e-05	0.000521	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MED12—adrenal gland cancer	2.53e-05	0.000519	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	2.53e-05	0.000518	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.46e-05	0.000504	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	2.45e-05	0.000502	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	2.43e-05	0.000498	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—BAD—adrenal gland cancer	2.41e-05	0.000494	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	2.41e-05	0.000494	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	2.41e-05	0.000493	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	2.37e-05	0.000486	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	2.37e-05	0.000485	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GNAS—adrenal gland cancer	2.3e-05	0.000471	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	2.25e-05	0.000462	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PRKACA—adrenal gland cancer	2.24e-05	0.000458	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—POMC—adrenal gland cancer	2.22e-05	0.000455	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	2.22e-05	0.000455	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	2.22e-05	0.000455	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	2.21e-05	0.000453	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	2.2e-05	0.000451	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—BRAF—adrenal gland cancer	2.2e-05	0.00045	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	2.19e-05	0.000448	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.19e-05	0.000448	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MED12—adrenal gland cancer	2.14e-05	0.000439	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	2.13e-05	0.000436	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—EGFR—adrenal gland cancer	2.13e-05	0.000436	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	2.11e-05	0.000432	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CTNNB1—adrenal gland cancer	2.07e-05	0.000424	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	2.06e-05	0.000422	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	2.04e-05	0.000418	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	2.03e-05	0.000416	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	2.01e-05	0.000412	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	2.01e-05	0.000411	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	2e-05	0.00041	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.96e-05	0.000402	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.96e-05	0.000401	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	1.94e-05	0.000398	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	1.94e-05	0.000397	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	1.92e-05	0.000393	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.92e-05	0.000393	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	1.87e-05	0.000384	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	1.85e-05	0.000378	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GNAS—adrenal gland cancer	1.81e-05	0.000371	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TP53—adrenal gland cancer	1.81e-05	0.000371	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ABCB1—adrenal gland cancer	1.78e-05	0.000364	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	1.78e-05	0.000364	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	1.77e-05	0.000363	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.66e-05	0.000339	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—EGFR—adrenal gland cancer	1.64e-05	0.000336	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	1.64e-05	0.000335	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GNAS—adrenal gland cancer	1.63e-05	0.000333	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	1.62e-05	0.000331	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	1.61e-05	0.00033	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	1.6e-05	0.000327	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.59e-05	0.000325	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CTNNB1—adrenal gland cancer	1.59e-05	0.000325	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	1.57e-05	0.000321	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	1.56e-05	0.00032	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—POMC—adrenal gland cancer	1.55e-05	0.000317	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	1.54e-05	0.000316	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.53e-05	0.000313	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	1.5e-05	0.000307	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	1.47e-05	0.000301	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	1.45e-05	0.000297	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—adrenal gland cancer	1.43e-05	0.000293	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	1.42e-05	0.000291	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	1.4e-05	0.000288	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	1.4e-05	0.000287	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—adrenal gland cancer	1.38e-05	0.000282	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	1.36e-05	0.000279	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	1.29e-05	0.000265	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	1.28e-05	0.000262	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GNAS—adrenal gland cancer	1.27e-05	0.00026	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EGFR—adrenal gland cancer	1.26e-05	0.000257	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	1.24e-05	0.000255	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	1.24e-05	0.000254	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	1.23e-05	0.000253	CbGpPWpGaD
Clomipramine—ALB—Metabolism—POMC—adrenal gland cancer	1.22e-05	0.00025	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.21e-05	0.000247	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	1.17e-05	0.000239	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	1.15e-05	0.000235	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.1e-05	0.000224	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—POMC—adrenal gland cancer	1.07e-05	0.000219	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—adrenal gland cancer	1.06e-05	0.000216	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.01e-05	0.000208	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.01e-05	0.000206	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	9.79e-06	0.0002	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—adrenal gland cancer	9.74e-06	0.000199	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	9.63e-06	0.000197	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	9.6e-06	0.000197	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	9.26e-06	0.00019	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	9.23e-06	0.000189	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	8.74e-06	0.000179	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—POMC—adrenal gland cancer	8.54e-06	0.000175	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	8.53e-06	0.000175	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	8.04e-06	0.000165	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	8.04e-06	0.000165	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	7.77e-06	0.000159	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	7.31e-06	0.00015	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	6.81e-06	0.000139	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	6.75e-06	0.000138	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—POMC—adrenal gland cancer	6.59e-06	0.000135	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	6.14e-06	0.000126	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	5.26e-06	0.000108	CbGpPWpGaD
